News

There was no association with microbiome-disturbing agents, but laxatives and antibiotics were independently associated with a more than 2-fold increase in the risk of acquiring an infection.

The clinician experience across specialties is crucial as the biosimilars market in the United States continues to expand.

The most common invasive fungal infection was histoplasmosis and the risk of invasive fungal infections was more than double in patients treated with corticosteroids than it was for patients treated with anti-TNFs.

At ATTD 2023, hosts Diana Isaacs, PharmD, and Natalie Bellini, DNP, have an extended conversation with the new chief operating officer at Dexcom, Jake Leach, to discuss the global and US rollouts of the Dexcom G7 and what the future might hold for Dexcom.

Previously known as efanesoctocog alfa, once-weekly ALTUVIIIO™ is indicated for routine prophylaxis and on-demand treatment to control bleeding episodes for adults and children with hemophilia A.

Investigators call for further research focusing on refining candidate selection for screening, improving the accuracy of LDCT scan reading, and integrating clinical risk models, imaging techniques, and biomarker research to enhance the probability evaluation of pulmonary nodule malignancy.

Findings from a recent study indicate a correlation between actual values of visual function and estimated values with a deep learning model using ultra-widefield FAF images.

A pilot study presented at ATTD 23 is providing further insight into the potential role of inhaled insulin in type 1 diabetes.

The results show a placebo-controlled trial is warranted in the future.

An analysis of data from AREDS2 suggests extramacular drusen in eyes with AMD are more frequent with an increased drusen burden within the macula.

In an interview segment with Kirby, she described her views on the need for future research into povorcitinib for hidradenitis suppurativa patients, as well as her outlook on treatment.

Electroacupuncture also resulted in a greater relief for the majority of OIC symptoms and improved the quality of life for this patient population and had no effects on cancer pain and its opioid treatment dosage.

In the interview, Kirby discussed recent trial data on povorcitinib indicating significant decreases in total abscess and inflammatory nodule count for hidradenitis suppurativa patients.

The historic FDA approval of pegcetacoplan marks the first and only approved treatment for geographic atrophy. In a new interview, Dr. Wykoff expresses what approval means for patients with the debilitating disease.

A cohort study of 1.9 million infants links exposure to fine particulate matter (PM2.5) to an increased risk of emergency department visits during the first year of life, with preterm and full-term infants being most susceptible during their fourth and fifth months.

Patients who were PCR positive or likely colonized in the two-step era were 20 times less likely to be associated with treatment for CDI, without adversely impacting patient outcomes.

Chovatiya discussed his Winter Clinical Miami presentation, common concerns over black box warnings for JAK inhibitors, and unmet needs of alopecia areata patients.

In his latest HCPLive interview, regarding a presentation at Winter Clinical Miami, Chovatiya spoke about recent JAK inhibitor developments, alopecia areata, baricitinib, and more.

A study from Slovenia suggests a physical activity intervention that would require physical activity every day while at school was effective for reducing BMI and reversing obesity in young children.

FMT was cost-effective compared to vancomycin in both the general CDI population, as well as the subset of patients with IBD. However, it was less cost-effective in compared to fidaxomicin.

Although the use of β-Blockers did not affect early-stage AMD, their long-term use was indicated to be protective against the risk of AMD among patients with hypertension.

The FDA assigned a PDUFA date of September 28, 2023 for the phentolamine ophthalmic solution 0.75%.

Phase 2 trial shows iron hydroxide adipate tartrate (IHAT) is non-inferior to ferrous sulfate (FeSO4) in correcting iron deficiency and hemoglobin response, with a lower incidence of moderate-severe diarrhea.

A new study indicates that OCTA-derived features of MNV disease activity may be useful biomarkers to confirm MNV stability in patients with treated stable nAMD.

Using the GWTG-HF registry, new data elucidates the differences in the likelihood of being prescribed GDMT among patients hospitalized with heart failure in rural compared to urban settings.

There was a 2.35-fold risk increase in PCCRC in the lowest ADR group compared to the highest.

The company announced more feedback from the FDA after receiving a Complete Response Letter last March.

An analysis of Veterans Affairs data from more than 20,000 people with diabetes provides an overview of the associations of CGM initiation with improved glycemic control and reduced hospitalization in this patient population.